Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Laskey

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
American Journal of Therapeutics|October 27, 2010
Systemic exposure to atorvastatin between Asian and Caucasian subjects: a combined analysis of 22 studiesKuan Gandelman, Gordon L Fung, Michael Messig, et al.
Pediatric Cardiology|January 25, 2011
An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemiaKuan Gandelman, Paul Glue, Rachel Laskey, et al.
Clinical Drug Investigation|June 3, 2017
Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without PsoriasisWilliam C Ports, Rana Fayyad, David A DeMicco, et al.
Journal of the Cardiometabolic Syndrome|September 6, 2007
Atorvastatin does not induce glomerular or tubular dysfunction even at high dosesMurray Epstein, Elizabeth Leary, Rachel Laskey, et al.
Cardiovascular Therapeutics|August 14, 2016
Safety of atorvastatin in Asian patients within clinical trialsJuliana C N Chan, Alice P S Kong, Weihang Bao, et al.
The New England Journal of Medicine|April 6, 2017
Body-Weight Fluctuations and Outcomes in Coronary DiseaseSripal Bangalore, Rana Fayyad, Rachel Laskey, et al.
European Heart Journal|August 31, 2013
Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trialSripal Bangalore, Rana Fayyad, Rachel Laskey, et al.
Journal of the American College of Cardiology|January 14, 2017
Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic AttackYoung Sup Byun, Xiaohong Yang, Weihang Bao, et al.
Journal of Clinical Lipidology|January 10, 2018
Visit-to-visit variability of lipid measurements as predictors of cardiovascular eventsDavid D Waters, Sripal Bangalore, Rana Fayyad, et al.
The American Journal of Medicine|November 10, 2015
2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?Sripal Bangalore, Rana Fayyad, John J Kastelein, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
American Journal of Therapeutics|October 27, 2010
Systemic exposure to atorvastatin between Asian and Caucasian subjects: a combined analysis of 22 studiesKuan Gandelman, Gordon L Fung, Michael Messig, et al.
Pediatric Cardiology|January 25, 2011
An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemiaKuan Gandelman, Paul Glue, Rachel Laskey, et al.
Clinical Drug Investigation|June 3, 2017
Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without PsoriasisWilliam C Ports, Rana Fayyad, David A DeMicco, et al.
Journal of the Cardiometabolic Syndrome|September 6, 2007
Atorvastatin does not induce glomerular or tubular dysfunction even at high dosesMurray Epstein, Elizabeth Leary, Rachel Laskey, et al.
Cardiovascular Therapeutics|August 14, 2016
Safety of atorvastatin in Asian patients within clinical trialsJuliana C N Chan, Alice P S Kong, Weihang Bao, et al.
The New England Journal of Medicine|April 6, 2017
Body-Weight Fluctuations and Outcomes in Coronary DiseaseSripal Bangalore, Rana Fayyad, Rachel Laskey, et al.
European Heart Journal|August 31, 2013
Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trialSripal Bangalore, Rana Fayyad, Rachel Laskey, et al.
Journal of the American College of Cardiology|January 14, 2017
Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic AttackYoung Sup Byun, Xiaohong Yang, Weihang Bao, et al.
Journal of Clinical Lipidology|January 10, 2018
Visit-to-visit variability of lipid measurements as predictors of cardiovascular eventsDavid D Waters, Sripal Bangalore, Rana Fayyad, et al.
The American Journal of Medicine|November 10, 2015
2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?Sripal Bangalore, Rana Fayyad, John J Kastelein, et al.
Pageof 2